Mount Sinai achieves milestone with first percutaneous tricuspid valve replacements
Mount Sinai Medical Center's interventional cardiology team successfully performed its first percutaneous tricuspid valve replacements, offering a less invasive option for high-risk patients.
Mount Sinai Medical Center’s interventional cardiology team has achieved a major milestone with the hospital’s first percutaneous tricuspid valve replacements, a breakthrough procedure offering new treatment options for patients who are too high-risk for open-heart surgery.
Led by Dr. Nirat Beohar, Director of Interventional Cardiology, and Dr. Andres Palomo, Interventional Cardiologist, the procedures were performed in collaboration with Dr. Angelo La Pietra, Director of Surgical Electrophysiology; Dr. Rafle Fernandez, Associate Director of Clinical Echocardiography; and Dr. Sofia Horvath Adam, Cardiologist.
The new transcatheter technique allows physicians to replace the diseased valve through a small catheter inserted into the leg, eliminating the need for open-heart surgery. Each procedure was completed in approximately 45 minutes, and both patients are recovering well.
